Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats.

Bayramgürler D, Karson A, Ozer C, Utkan T.

Physiol Behav. 2013 Jul 2;119:145-8. doi: 10.1016/j.physbeh.2013.06.010. Epub 2013 Jun 13.

PMID:
23769689
2.

Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress.

Karson A, Demirtaş T, Bayramgürler D, Balci F, Utkan T.

Basic Clin Pharmacol Toxicol. 2013 May;112(5):335-40. doi: 10.1111/bcpt.12037. Epub 2013 Jan 19.

3.

Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α.

Chio CC, Chang CH, Wang CC, Cheong CU, Chao CM, Cheng BC, Yang CZ, Chang CP.

BMC Neurosci. 2013 Mar 15;14:33. doi: 10.1186/1471-2202-14-33.

4.

Antidepressant effects of TNF-α blockade in an animal model of depression.

Krügel U, Fischer J, Radicke S, Sack U, Himmerich H.

J Psychiatr Res. 2013 May;47(5):611-6. doi: 10.1016/j.jpsychires.2013.01.007. Epub 2013 Feb 6.

PMID:
23394815
5.

Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin.

O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R.

J Neurosci. 2009 Apr 1;29(13):4200-9. doi: 10.1523/JNEUROSCI.5032-08.2009.

6.

Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model.

Zanella JM, Burright EN, Hildebrand K, Hobot C, Cox M, Christoferson L, McKay WF.

Spine (Phila Pa 1976). 2008 Feb 1;33(3):227-34. doi: 10.1097/BRS.0b013e318162340a.

PMID:
18303453
7.

Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.

Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, Siriwardena AK, Cuzzocrea S.

Shock. 2007 May;27(5):542-51.

PMID:
17438460
8.

Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury.

Chen KB, Uchida K, Nakajima H, Yayama T, Hirai T, Watanabe S, Guerrero AR, Kobayashi S, Ma WY, Liu SY, Baba H.

Spine (Phila Pa 1976). 2011 Aug 1;36(17):1350-8. doi: 10.1097/BRS.0b013e3181f014ec.

PMID:
21224756
9.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

10.

Etanercept: efficacy and safety for approved indications.

Kerensky TA, Gottlieb AB, Yaniv S, Au SC.

Expert Opin Drug Saf. 2012 Jan;11(1):121-39. doi: 10.1517/14740338.2012.633509. Epub 2011 Nov 11. Review.

PMID:
22074366
11.

Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study.

Lestre S, Diamantino F, Veloso L, Fidalgo A, Ferreira A.

Eur J Dermatol. 2011 Nov-Dec;21(6):916-20. doi: 10.1684/ejd.2011.1548.

PMID:
21983007
12.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

13.

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.

Goldenberg MM.

Clin Ther. 1999 Jan;21(1):75-87; discussion 1-2. Review.

PMID:
10090426
14.

Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury.

Choi DE, Jeong JY, Lim BJ, Na KR, Shin YT, Lee KW.

Transplant Proc. 2009 Nov;41(9):3590-6. doi: 10.1016/j.transproceed.2009.05.042.

PMID:
19917350
15.

Direct application of the TNF-alpha inhibitor, etanercept, does not affect CGRP expression and phenotypic change of DRG neurons following application of nucleus pulposus onto injured sciatic nerves in rats.

Norimoto M, Ohtori S, Yamashita M, Inoue G, Yamauchi K, Koshi T, Suzuki M, Orita S, Eguchi Y, Sugiura A, Ochiai N, Takaso M, Takahashi K.

Spine (Phila Pa 1976). 2008 Oct 15;33(22):2403-8. doi: 10.1097/BRS.0b013e31818441a2.

PMID:
18824950
16.
17.

Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.

Serova LI, Laukova M, Alaluf LG, Pucillo L, Sabban EL.

Eur Neuropsychopharmacol. 2014 Jan;24(1):142-7. doi: 10.1016/j.euroneuro.2013.11.007. Epub 2013 Nov 23.

PMID:
24326087
18.

Etanercept treatment in the endotoxin-induced uveitis of rats.

Avunduk MC, Avunduk AM, Oztekin E, Baltaci AK, Ozyazgan Y, Mogolkoc R.

Exp Eye Res. 2004 Sep;79(3):357-65.

PMID:
15336498
19.

Etanercept attenuates pain-related behavior following compression of the dorsal root ganglion in the rat.

Watanabe K, Yabuki S, Sekiguchi M, Kikuchi S, Konno S.

Eur Spine J. 2011 Nov;20(11):1877-84. doi: 10.1007/s00586-011-1854-y. Epub 2011 Jun 2.

20.

Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liver.

Viswanathan P, Kapoor S, Kumaran V, Joseph B, Gupta S.

Hepatology. 2014 Oct;60(4):1378-88. doi: 10.1002/hep.27232. Epub 2014 Sep 9.

Supplemental Content

Support Center